Migration from RIA to LC-MS/MS for aldosterone determination: Implications for clinical practice and determination of plasma and urine reference range intervals in a cohort of healthy Belgian subjects
LE GOFF, Caroline; Gonzalez-Antuña, Ana; PEETERS, Stéphanieet al.
2018 • In Clinical Mass Spectrometry, 9, p. 7 - 17
Aldosterone; Primary aldosteronism; Liquid chromatography; Mass spectrometry; Immunoassay
Abstract :
[en] Background Aldosterone measurement is critical for diagnosis of primary aldosteronism and disorders of the renin-angiotensin system. We developed an LC-MS/MS method for plasma and urinary aldosterone and compared it to our RIA method. We present a reference interval study for a Belgian population. Methods 68 plasma and 23 urine samples were assayed for as part of a method comparison. For the reference interval study, we enrolled 282 healthy Caucasian volunteers (114 Male: mean age 35 ± 11 y and 168 Female: mean age 42 ± 13 y). A subset of 139 healthy volunteers agreed to a 24-h urine collection. For the method validation, 5 plasma and 8 urine pools were run in triplicate and quadruplicate, respectively, on 3 different days. Results Between-run imprecision (CV) was 2.8–5.1% for plasma and 4.5–8.6% for urine, except at the low urine concentration of 2.99 nmol/L where a CV of 15.4% was observed. The limit of quantitation was 0.04 nmol/L for plasma and 6.65 nmol/L for urine. Recoveries, based on spiking experiments into natural matrix, did not differ significantly from 100%. Regression comparisons showed that, on average, RIA generated results were 59% and 11% higher than LC-MS/MS for plasma and urine, respectively. The MS reference interval we propose for plasma aldosterone is 0.07 nmol/L–0.73 nmol/L for women and 0.04 nmol/L–0.41 nmol/L for men. No gender difference was observed for urine aldosterone. The reference interval was determined to be <60.94 nmol/day. Conclusions The LC-MS/MS method was validated and reference intervals for plasma and urine were established. A significant bias between RIA and LC-MS/MS was noted.
Disciplines :
Endocrinology, metabolism & nutrition Laboratory medicine & medical technology
Author, co-author :
LE GOFF, Caroline ; Centre Hospitalier Universitaire de Liège - CHU > Unilab > Laboratoire techniques séparatives et stress oxydant
Gonzalez-Antuña, Ana
PEETERS, Stéphanie ; Centre Hospitalier Universitaire de Liège - CHU > Unilab > Laboratoire techniques séparatives et stress oxydant
Fabregat Cabello, Neus ; Université de Liège - ULiège > Département de pharmacie > Chimie médicale
Gugten, Jessica G. Van Der
VROONEN, Laurent ; Centre Hospitalier Universitaire de Liège - CHU > Département de médecine interne > Service d'endocrinologie clinique
Pottel, Hans
Holmes, Daniel T.
Cavalier, Etienne ; Université de Liège - ULiège > Département de pharmacie > Chimie médicale
Language :
English
Title :
Migration from RIA to LC-MS/MS for aldosterone determination: Implications for clinical practice and determination of plasma and urine reference range intervals in a cohort of healthy Belgian subjects
Conn, J., Primary aldosteronism, a new clinical syndrome. J. Lab. Clin. Med. 45 (1955), 3–17.
Quinkler, M., Born-Frontsberg, E.F.V., Comorbidities in primary aldosteronism. Horm. Metab. Res. 42 (2010), 429–434.
Lee, S.-G., Lee, W., Kwon, O.H., Kim, J.-H., Association of urinary sodium/creatinine ratio and urinary sodium/specific gravity unit ratio with blood pressure and hypertension: KNHANES 2009–2010. Clin. Chim. Acta. Elsevier B.V. 424 (2013), 168–173.
World Health Organization. A global brief on Hypertension - World Health Day 201World Heal Organ. 2013;1–40.
Chockalingam, A., Impact of World Hypertension Day. Can. J. Cardiol. 23:7 (2007), 517–519.
Horton, R., Aldosterone and aldosteronism. Steroids 68:14 (2003), 1135–1138.
Galati, Sandi-Jo, Primary aldosteronism: challenges in diagnosis and management. Endocrinol. Metab. Clin. North Am. 44 (2015), 355–369.
Ceral, J., Malirova, E., Ballon, M.S.M., The role of urinary aldosterone for the diagnosis of primary aldosteronism. Horm. Metab. Res. 46:9 (2014), 663–667.
Hannemann, A., Friedrich, N., Lüdemann, J., Völzke, H., Rettig, R., Peters, J., et al. Reference intervals for aldosterone, renin, and the aldosterone-to-renin ratio in the population-based Study of Health in Pomerania (SHIP-1). Horm. Metab. Res. 42:6 (2010), 392–399.
Stowasser, M., Taylor, P.J., Pimenta, E., Ahmed, A.H.A.-A., Gordon, R.D., Laboratory investigation of primary aldosteronism. Clin. Biochem. Rev. 31:2 (2010), 39–56.
Pizzolo, F., Rafaeli, R., Chiecchi, L., Pavan, C.G.P., et al. Effects of female sex hormones and contraceptives pill on the diagnostic work-up for primary aldosteronism. J. Clin. Endocrinol. Metab. Clin. Endocrinol. Metab. 28 (2010), 135–142.
Yalow, R.S., Berson, S.A., Immunoassay of endogenous plasma insulin in man. J. Clin. Invest. 39 (1960), 1157–1175.
Dorrian, C.A., Toole, B.J., Alvarez-Madrazo, S., Kelly, A., Connell, J.M.W.A., A screening procedure for primary aldosteronism based on the Diasorin Laision automated chemilumuniscent immunoassay for direct renin. Ann. Clin. Biochem. 47 (2010), 195–200.
Stowasser, M.G.R., Aldosterone assays: an urgent need for improvement. Clin. Chem. 9:9 (2006), 1640–1642.
Belaidi, N., Georges, A., Brossaud, J., Corcuff, J.-B., Aldosterone determination: Comparison of a RIA assay and a CLIA assay. Clin. Biochem. The Canadian Soc. Clin. Chem. 48:1–2 (2015), 89–92.
Al-Dujaili, E.A., Edwards, C.R., Development and application of a simple radioimmunoassay for urinary aldosterone. Clin. Chim. Acta; Int. J. Clin. Chem., 1981, 277–287.
Fredline, V.F., Taylor, P.J., Dodds, H.M., Johnson, G.A., A reference method for the analysis of aldosterone in blood by high-performance liquid chromatography-atmospheric pressure chemical ionization-tandem mass spectrometry. Anal. Biochem. 252:252 (1997), 308–313.
S. Becker, L. Kortz, C. Helmschrodt, J. Thiery, U. Ceglarek, R.M. Büttler, et al., Clinica Chimica Acta Measurement of dehydroepiandrosterone sulphate (DHEAS): A comparison of Isotope-Dilution Liquid Chromatography Tandem Mass Spectrometry (ID-LC-MS/MS) and seven currently available immunoassays, Clin. Chim. Acta. Elsevier B.V.; 424(May 2012) (2013) 68–75. Available from.
Allen, K.R., Azad, R., Field, H.P.B.D., Replacement of immunoassay by LC tandem mass spectrometry for the routine measurement of drugs of abuse in oral fluid. Ann. Clin. Biochem. 42 (2005), 277–284.
Ray, J.A., Kushnir, M.M., Palmer, J., Sadjadi, S., Rockwood, A.L., Meikle, A.W., Enhancement of specificity of aldosterone measurement in human serum and plasma using 2D-LC-MS/MS and comparison with commercial immunoassays. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. Elsevier B.V. 970 (2014), 102–107.
Vogeser, M., Kirchhoff, F., Progress in automation of LC-MS in laboratory medicine. Clin. Biochem. The Canadian Soc. Clin. Chem. 44:1 (2011), 4–13.
Grebe, S.K.G., Singh, R.J., LC-MS/MS in the clinical laboratory - Where to from here?. Clin. Biochem. Rev. 32:1 (2011), 5–31.
Becker, S., Kortz, L., Helmschrodt, C., Thiery, J., Ceglarek, U., LC–MS-based metabolomics in the clinical laboratory. J. Chromatogr. B. Elsevier B.V. 883–884 (2012), 68–75.
Van Der Gugten, J.G., Dubland, J., Liu, H.-F., Wang, A., Joseph, C., Holmes, D.T., Determination of serum aldosterone by liquid chromatography and tandem mass spectrometry: a liquid-liquid extraction method for the ABSCIEX API-5000 mass spectrometry system. J. Clin. Pathol. 65:5 (2012), 457–462.
Hinchliffe, E., Carter, S., Owen, L.J., Keevil, B.G., Quantitation of aldosterone in human plasma by ultra high performance liquid chromatography tandem mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed Life Sci. Elsevier B.V. 913–914 (2013), 19–23.
Taylor, P.J., Cooper, D.P., Gordon, R.D., Stowasser, M., Measurement of aldosterone in human plasma by semiautomated HPLC-tandem mass spectrometry. Clin. Chem. 55:6 (2009), 1155–1162.
Guo, T., Taylor, R.L., Singh, R.J., Soldin, S.J., Simultaneous determination of 12 steroids by isotope dilution liquid chromatography-photospray ionization tandem mass spectrometry. Clin. Chim. Acta. 372:1–2 (2006), 76–82.
Meunier, C., Blondelle, D., Faure, P., Baguet, J.-P., Le Goff, C., Chabre, O., et al. Development and validation of a method using supported liquid extraction for aldosterone determination in human plasma by LC-MS/MS. Clin. Chim. Acta., 447, 2015.
Food and Drug Administration, Guidance for Industry: Bioanalytical Method Validation, US Dep Heal Hum Serv. (May) (2001) 4–10.
P.A. Wayne, EP06-A: Evaluation of the Linearity of Quantitative Measurement Procedures: A Statistical Approach; Approved Guideline, Approv Guidel CLSI Doc EP6-A (April) (2003) 23.
Meunier, C., Blondelle, D., Faure, P., Baguet, J.-P., Le Goff, C., Chabre, O., et al. Development and validation of a method using supported liquid extraction for aldosterone determination in human plasma by LC-MS/MS. Clin. Chim. Acta. Elsevier B.V. 447 (2015), 8–15.
Organization World Health. WHO | Sodium intake for adults and children. World Heal Organ [Internet]. 2012;(ISBN 978 92 4 150483 6):56. Available from: http://www.ncbi.nlm.nih.gov/pubmed?term=Sodium[Title] AND intake[Title] AND adults[Title] AND children[Title] AND WHO[Title].
Harris, E.K., Boyd, J.C., On dividing reference data into subgroups to produce separate reference ranges. Clin. Chem. 36:2 (1990), 265–270.
Tukey, J.W., Exploratory Data Analysis. 1977, Addison-Wesely.
Funder, J.W., Carey, R.M., Fardella, C., Gomez-Sanchez, C.E., Mantero, F., Stowasser, M., et al. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 93:9 (2008), 3266–3281.
Ricós, C., Iglesias, N., García-Lario, J.-V., Simón, M., Cava, F., Hernández, A., et al. Within-subject biological variation in disease: collated data and clinical consequences. Ann. Clin. Biochem. 44 (2007), 343–352.
Ahokoski, O., Virtanen, A., Kairisto, V., Scheinin, H., Huupponen, R., Irjala, K., Biological day-to-day variation and reference change limits of serum cortisol and aldosterone in healthy young men on unrestricted diets. Clin. Chem. 45:7 (1999), 1097–1099.
Fortunato, A., Prontera, C., Masotti, S., Franzini, M., Marchetti, C., Giovannini, S., et al. State of the art of aldosterone immunoassays. A multicenter collaborative study on the behalf of the Cardiovascular Biomarkers Study Group of the Italian Section of European Society of Ligand Assay (ELAS) and Società Italiana di Biochimica Clinica (SIBIOC. Clin Chim Acta. Elsevier B.V. 444 (2015), 106–112.
Cho, H.-J., Kim, J.D., Lee, W.-Y., Chung, B.C., Choi, M.H., Quantitative metabolic profiling of 21 endogenous corticosteroids in urine by liquid chromatography-triple quadrupole-mass spectrometry. Anal. Chim. Acta. 632:1 (2009), 101–108.
Rehan, M., Raizman, J.E., Cavalier, E., Don-Wauchope, A.C., Holmes, D.T., Laboratory challenges in primary aldosteronism screening and diagnosis. Clin. Biochem. 48:6 (2015), 377–387.
Drenjacnevic-Peric, I., Jelaković, B., Lombard, J.H., Kunert, M.P., Kibel, A., Gros, M., High-salt diet and hypertension: Focus on the renin-angiotensin system. Kidney Blood Press Res. 34:1 (2011), 1–11.
Vandevijvere, S., De Keyzer, W., Chapelle, J.-P., Jeanne, D., Mouillet, G., Huybrechts, I., et al. Estimate of total salt intake in two regions of Belgium through analysis of sodium in 24-h urine samples. Eur. J. Clin. Nutr. Nature Publishing Group 64:11 (2010), 1260–1265.
Eisenhofer, G., Peitzsch, M., Kaden, D., Langton, K., Pamporaki, C., Masjkur, J., et al. Reference intervals for plasma concentrations of adrenal steroids measured by LC-MS/MS: Impact of gender, age, oral contraceptives, body mass index and blood pressure status. Clin. Chim. Acta., 470, 2017.
O'Shea, P., Brady, J.J., Gallagher, N., Dennedy, M.C., Fitzgibbon, M., Establishment of reference intervals for aldosterone and renin in a Caucasian population using the newly developed Immunodiagnostic Systems specialty immunoassay automated system. Ann. Clin. Biochem. An Int. J. Biochem. Lab. Med.(August), 2015, 1–9.
Y. Bekkach, A.C. Heijboer, E. Endert, Determination of urinary aldosterone using a plasma aldosterone 2D ID LC–MS/MS method. 8 (2016) 1765–1775.
Eisenhofer, G., Peitzsch, M., Kaden, D., Langton, K., Pamporaki, C., Masjkur, J., et al. Clinica Chimica Acta Reference intervals for plasma concentrations of adrenal steroids measured by LC-MS/MS: impact of gender, age, oral contraceptives, body mass index and blood pressure status. Clin. Chim. Acta. Elsevier 470:June 2016 (2017), 115–124.
